Breast international group (BIG) – aisbl
Rue de bretagne 20,
1200 Brussels, Belgium
VAT BE 0468 176 240
IBAN BE08 0689 0916 0213
Navigation
The Breast International Group is proud to adhere
to the Code of Ethics of the VEF-AERF
About BIG​
Together we will find cures for breast cancer.​
Breast International Group
The Breast International Group (BIG) is an international not-for-profit organisation founded over 20 years ago by Professors Martine Piccart and Aron Goldhirsch. It now represents the largest global network of academic research groups dedicated to finding better treatments and cures for breast cancer.Â
Its mission is to facilitate and accelerate breast cancer research at an international level. BIG thinks globally and acts locally, helping breast cancer patients from all over the world.Â
BIG against breast cancer was created to raise funds and help finance clinical trials and research programmes initiated by BIG that have no commercial interest but are crucial for patients.Â
Together we will find cures for breast cancer.
Our mission
BIG’s mission is to facilitate and accelerate breast cancer research at the international level.
Our vision
Together we will find a cure for breast cancer through global research and collaboration.
Global & local
BIG is the largest global network of breast cancer research groups and their affiliated experts. Their work benefits patients locally.
Impactful
Our research changes practice in the treatment of women and men with breast cancer. We have a real impact on patients’ lives.
Strategy statement
We believe that it is possible to develop cures for breast cancer through global research and collaboration; our mission is therefore to facilitate and accelerate academic breast cancer research at an international level, and to do so by enabling groups to do more than their individual parts.
Principles of research conduct
We operate according to a series of principles of research conduct focused on ensuring scientific integrity in trial design and governance.Â
These principles aim to eliminate bias from the research process, and maintain integrity vis à vis patients, both when working with pharmaceutical partners or when working alone. Furthermore, all BIG studies are governed by committees and policies aiming to ensure that patients’ best interests stay in focus at every step of the way.